Literature DB >> 32358960

Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools.

Idan Yelin1, Noga Aharony1, Einat Shaer Tamar1, Amir Argoetti1, Esther Messer2, Dina Berenbaum1, Einat Shafran3, Areen Kuzli3, Nagham Gandali3, Omer Shkedi4, Tamar Hashimshony1, Yael Mandel-Gutfreund1,5, Michael Halberthal4,6, Yuval Geffen7, Moran Szwarcwort-Cohen3, Roy Kishony1,5.   

Abstract

BACKGROUND: The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to a current pandemic of unprecedented scale. Although diagnostic tests are fundamental to the ability to detect and respond, overwhelmed healthcare systems are already experiencing shortages of reagents associated with this test, calling for a lean immediately applicable protocol.
METHODS: RNA extracts of positive samples were tested for the presence of SARS-CoV-2 using reverse transcription quantitative polymerase chain reaction, alone or in pools of different sizes (2-, 4-, 8-, 16-, 32-, and 64-sample pools) with negative samples. Transport media of additional 3 positive samples were also tested when mixed with transport media of negative samples in pools of 8.
RESULTS: A single positive sample can be detected in pools of up to 32 samples, using the standard kits and protocols, with an estimated false negative rate of 10%. Detection of positive samples diluted in even up to 64 samples may also be attainable, although this may require additional amplification cycles. Single positive samples can be detected when pooling either after or prior to RNA extraction.
CONCLUSIONS: As it uses the standard protocols, reagents, and equipment, this pooling method can be applied immediately in current clinical testing laboratories. We hope that such implementation of a pool test for coronavirus disease 2019 would allow expanding current screening capacities, thereby enabling the expansion of detection in the community, as well as in close organic groups, such as hospital departments, army units, or factory shifts.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; diagnostics; disease surveillance

Mesh:

Year:  2020        PMID: 32358960      PMCID: PMC7197588          DOI: 10.1093/cid/ciaa531

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  135 in total

Review 1.  Considerations for Group Testing: A Practical Approach for the Clinical Laboratory.

Authors:  Jun G Tan; Aznan Omar; Wendy By Lee; Moh S Wong
Journal:  Clin Biochem Rev       Date:  2020-12

2.  THE AUTHOR REPLIES.

Authors:  Clarice R Weinberg
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897

3.  DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to Potential for False Negatives and Underreporting of Viral Infection.

Authors:  Adam P Rosebrock
Journal:  Clin Chem       Date:  2021-01-30       Impact factor: 8.327

4.  Analysis of multi-sample pools in the detection of SARS-CoV-2 RNA for mass screening: An Indian perspective.

Authors:  Sangeeta Deka; Deepjyoti Kalita; Amit Mangla; Ravi Shankar
Journal:  Indian J Med Microbiol       Date:  2020 Jul-Dec       Impact factor: 0.985

5.  The Right Kind of Pooled Testing for the Novel Coronavirus: First, Do No Harm.

Authors:  Eugene Litvak; Susan Dentzer; Marcello Pagano
Journal:  Am J Public Health       Date:  2020-09-24       Impact factor: 9.308

6.  Leveraging Africa's preparedness towards the next phase of the COVID-19 pandemic.

Authors:  Madikay Senghore; Merveille K Savi; Bénédicte Gnangnon; William P Hanage; Iruka N Okeke
Journal:  Lancet Glob Health       Date:  2020-05-14       Impact factor: 26.763

7.  Containing pandemics through targeted testing of households.

Authors:  André Voigt; Nikolay Martyushenko; Emil Karlsen; Martina Hall; Kristen Nyhamar; Stig William Omholt; Eivind Almaas
Journal:  BMC Infect Dis       Date:  2021-06-09       Impact factor: 3.090

8.  COVID-19 Sample Pooling: From RNA Extraction to Quantitative Real-time RT-PCR.

Authors:  Kenny Voon; Nur Alia Johari; Khai Lone Lim; Siew Tung Wong; Loke Tim Khaw; Shew Fung Wong; Elaine W L Chan; Kok Keong Chan; Boon Keat Tan; Nurul Hanis Ramzi; Patricia K C Lim; Lokman H Sulaiman
Journal:  Bio Protoc       Date:  2021-05-05

Review 9.  Misdiagnosis of SARS-CoV-2: A Critical Review of the Influence of Sampling and Clinical Detection Methods.

Authors:  Daniel Keaney; Shane Whelan; Karen Finn; Brigid Lucey
Journal:  Med Sci (Basel)       Date:  2021-05-25

10.  Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?

Authors:  Catherine P Adans-Dester; Stacy Bamberg; Francesco P Bertacchi; Brian Caulfield; Kara Chappie; Danilo Demarchi; M Kelley Erb; Juan Estrada; Eric E Fabara; Michael Freni; Karl E Friedl; Roozbeh Ghaffari; Geoffrey Gill; Mark S Greenberg; Reed W Hoyt; Emil Jovanov; Christoph M Kanzler; Dina Katabi; Meredith Kernan; Colleen Kigin; Sunghoon I Lee; Steffen Leonhardt; Nigel H Lovell; Jose Mantilla; Thomas H McCoy; Nell Meosky Luo; Glenn A Miller; John Moore; Derek O'Keeffe; Jeffrey Palmer; Federico Parisi; Shyamal Patel; Jack Po; Benito L Pugliese; Thomas Quatieri; Tauhidur Rahman; Nathan Ramasarma; John A Rogers; Guillermo U Ruiz-Esparza; Stefano Sapienza; Gregory Schiurring; Lee Schwamm; Hadi Shafiee; Sara Kelly Silacci; Nathaniel M Sims; Tanya Talkar; William J Tharion; James A Toombs; Christopher Uschnig; Gloria P Vergara-Diaz; Paul Wacnik; May D Wang; James Welch; Lina Williamson; Ross Zafonte; Adrian Zai; Yuan-Ting Zhang; Guillermo J Tearney; Rushdy Ahmad; David R Walt; Paolo Bonato
Journal:  IEEE Open J Eng Med Biol       Date:  2020-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.